OTC · ADXS
Ayala Pharmaceuticals, Inc.
$0.60$0.00 (0.0%)
Ayala Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 24.65% below the high.
Loading market information…
OTC · PSYGF · USD
Stock price, earnings
Quote as of Aug 6, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Psyence Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Psyence Group Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Psyence Group, Inc. is a life science biotechnology company, which engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. Its divisions include Psyence Production and Psyence Therapeutics. The company was founded by Jody Aufrichtig on March 26, 1994 and is headquartered in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.60$0.00 (0.0%)
Ayala Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 24.65% below the high.
CA$0.07-CA$0.01 (-7.14%)
Restart Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 51.85% below the high.
$0.00-$0.00 (-30.0%)
Indo Global Exchange(s) PTE, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.25% below the high.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
$0.00$0.00 (0.0%)
Kaya Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.57% below the high.
$0.01-$0.00 (-24.64%)
Genix Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 70.89% below the high.
$0.00$0.00 (0.0%)
ReNeuron Group plc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Resonate Blends, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.6% below the high.
